Grant of share options
Nykode Therapeutics ASA (NYKD) · publisert 16. mai 2022 kl. 20:50 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Birgitte Volck | Styremedlem | Annet Tildeling | 45 000 | 0 NOK | 16. mai 2022 | NO0010714785 | Outside of trading venue |
| Michael Engsig | CEO | Annet Tildeling | 334 927 | 0 NOK | 16. mai 2022 | NO0010714785 | Outside of trading venue |
| Harald Gurvin | CFO | Annet Tildeling | 140 214 | 0 NOK | 16. mai 2022 | NO0010714785 | Outside of trading venue |
| Agnete B. Fredriksen | Chief Innovation & Strategy Officer | Annet Tildeling | 128 997 | 0 NOK | 16. mai 2022 | NO0010714785 | Outside of trading venue |
| Mikkel W. Pedersen | Chief Scientific Officer | Annet Tildeling | 123 348 | 0 NOK | 16. mai 2022 | NO0010714785 | Outside of trading venue |
| Mette Husbyn | Chief Technology Officer | Annet Tildeling | 55 777 | 0 NOK | 16. mai 2022 | NO0010714785 | Outside of trading venue |
| Katrine Husum | Senior Director, Head of Project and Alliance Management | Annet Tildeling | 56 383 | 0 NOK | 16. mai 2022 | NO0010714785 | Outside of trading venue |
| Martin Nicklasson | Styreleder | Annet Tildeling | 200 000 | 0 NOK | 16. mai 2022 | NO0010714785 | Outside of trading venue |
| Anders Tuv | Styremedlem | Annet Tildeling | 45 000 | 0 NOK | 16. mai 2022 | NO0010714785 | Outside of trading venue |
| Anne Whitaker | Styremedlem | Annet Tildeling | 45 000 | 0 NOK | 16. mai 2022 | NO0010714785 | Outside of trading venue |
| Elaine Sullivan | Styremedlem | Annet Tildeling | 45 000 | 0 NOK | 16. mai 2022 | NO0010714785 | Outside of trading venue |
| Bernd R. Seizinger | Styremedlem | Annet Tildeling | 45 000 | 0 NOK | 16. mai 2022 | NO0010714785 | Outside of trading venue |
Vedlegg
- Attachment 220516.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, Norway, May 16, 2022 - Reference is made to the Annual General Meeting (AGM) in Nykode Therapeutics AS held on May 12, 2022, where the grant of share options to certain members of the Board was approved. A total of 425,000 share options with a strike price of NOK 31.90 per share have been granted in line with the terms set out in the minutes from the AGM.
Further, a total of 1,450,987 share options have been granted to employees of Nykode Therapeutics AS under the company’s share option scheme, of which 839,646 share options have been granted to primary insiders. The share options will have a strike price of NOK 34.99 per share, have a five-year term and will vest equally over a four-year vesting period.
Please see further details in attached document.